ORYZON GENOMICS, S.A. «...111213» Page 13 out of 13 17/04/2020 18:17 ORYZON GENOMICS, S.A. On corporate governance ORYZON announces the incorporation of a new Independent Director to its Board of Directors Register number: 1612 03/04/2020 07:32 ORYZON GENOMICS, S.A. Other relevant information ORYZON presents preliminary efficacy data of vafidemstat from its two Phase IIa clinical trials in Alzheimer’s, REIMAGINE-AD and ETHERAL Register number: 1373 25/02/2020 07:57 ORYZON GENOMICS, S.A. On corporate governance ORYZON remite nota de prensa en relación con un cambio en su Consejo de Administración Register number: 244 24/02/2020 08:11 ORYZON GENOMICS, S.A. Other relevant information Oryzon publish its 2019 final year results press release (Spanish) Register number: 203 24/02/2020 07:53 ORYZON GENOMICS, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2019 Register number: 202 24/02/2020 07:48 ORYZON GENOMICS, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del segundo semestre de 2019 Register number: 201 24/02/2020 07:18 ORYZON GENOMICS, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2019 Register number: 196 Page 13 out of 13 «...111213»
